These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 20505341)
1. p85 plays a critical role in controlling flux through the PI3K/PTEN signaling axis through dual regulation of both p110 (PI3K) and PTEN. Anderson DH Cell Cycle; 2010 Jun; 9(11):2055-6. PubMed ID: 20505341 [No Abstract] [Full Text] [Related]
2. Overview of the regulation of the class IA PI3K/AKT pathway by SUMO. Vidal S; Bouzaher YH; El Motiam A; Seoane R; Rivas C Semin Cell Dev Biol; 2022 Dec; 132():51-61. PubMed ID: 34753687 [TBL] [Abstract][Full Text] [Related]
3. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase. Chagpar RB; Links PH; Pastor MC; Furber LA; Hawrysh AD; Chamberlain MD; Anderson DH Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5471-6. PubMed ID: 20212113 [TBL] [Abstract][Full Text] [Related]
4. BRD7, a tumor suppressor, interacts with p85α and regulates PI3K activity. Chiu YH; Lee JY; Cantley LC Mol Cell; 2014 Apr; 54(1):193-202. PubMed ID: 24657164 [TBL] [Abstract][Full Text] [Related]
5. [The effects of ceruloplasmin in PI3K/PTEN cell signaling pathway change induced by silica]. Zhang X; Li Y; Jia X; Liu B; Ye M Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 Apr; 32(4):241-5. PubMed ID: 24754934 [TBL] [Abstract][Full Text] [Related]
6. PTEN regulation, a novel function for the p85 subunit of phosphoinositide 3-kinase. Barber DF; Alvarado-Kristensson M; González-García A; Pulido R; Carrera AC Sci STKE; 2006 Nov; 2006(362):pe49. PubMed ID: 17119157 [TBL] [Abstract][Full Text] [Related]
7. The gene dosage of class Ia PI3K dictates the development of PTEN hamartoma tumor syndrome. Wang Q; Weisberg E; Zhao JJ Cell Cycle; 2013 Dec; 12(23):3589-93. PubMed ID: 24131925 [TBL] [Abstract][Full Text] [Related]
8. A beta version of life: p110β takes center stage. Dbouk HA; Backer JM Oncotarget; 2010 Dec; 1(8):729-733. PubMed ID: 21321382 [TBL] [Abstract][Full Text] [Related]
9. Impact of p85α Alterations in Cancer. Marshall JDS; Whitecross DE; Mellor P; Anderson DH Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30650664 [TBL] [Abstract][Full Text] [Related]
10. LZTS2 inhibits PI3K/AKT activation and radioresistance in nasopharyngeal carcinoma by interacting with p85. Xu S; Li Y; Lu Y; Huang J; Ren J; Zhang S; Yin Z; Huang K; Wu G; Yang K Cancer Lett; 2018 Apr; 420():38-48. PubMed ID: 29409973 [TBL] [Abstract][Full Text] [Related]
11. Regulation of the PI3K pathway through a p85α monomer-homodimer equilibrium. Cheung LW; Walkiewicz KW; Besong TM; Guo H; Hawke DH; Arold ST; Mills GB Elife; 2015 Jul; 4():e06866. PubMed ID: 26222500 [TBL] [Abstract][Full Text] [Related]
12. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast. Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452 [TBL] [Abstract][Full Text] [Related]
13. Nuclear phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-kinase, Akt, and PTen: emerging key regulators of anti-apoptotic signaling and carcinogenesis. Martelli AM; Cocco L; Capitani S; Miscia S; Papa S; Manzoli FA Eur J Histochem; 2007; 51 Suppl 1():125-31. PubMed ID: 17703603 [TBL] [Abstract][Full Text] [Related]
14. Rac1-mediated membrane raft localization of PI3K/p110β is required for its activation by GPCRs or PTEN loss. Cizmecioglu O; Ni J; Xie S; Zhao JJ; Roberts TM Elife; 2016 Oct; 5():. PubMed ID: 27700986 [TBL] [Abstract][Full Text] [Related]
16. Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance. Zuo Q; Liu J; Zhang J; Wu M; Guo L; Liao W Sci Rep; 2015 Jun; 5():11634. PubMed ID: 26108989 [TBL] [Abstract][Full Text] [Related]
17. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Carnero A; Blanco-Aparicio C; Renner O; Link W; Leal JF Curr Cancer Drug Targets; 2008 May; 8(3):187-98. PubMed ID: 18473732 [TBL] [Abstract][Full Text] [Related]
18. High levels of p110δ PI3K expression in solid tumor cells suppress PTEN activity, generating cellular sensitivity to p110δ inhibitors through PTEN activation. Tzenaki N; Andreou M; Stratigi K; Vergetaki A; Makrigiannakis A; Vanhaesebroeck B; Papakonstanti EA FASEB J; 2012 Jun; 26(6):2498-508. PubMed ID: 22391131 [TBL] [Abstract][Full Text] [Related]
19. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy. Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996 [TBL] [Abstract][Full Text] [Related]
20. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits. Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]